Cytokinetics reported $66.84M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Amgen AMGN:US $ 12618M 268M
Arca Biopharma ABIO:US $ 3.5M 0.62M
Bayer BAYN:GR € 33643M 2624M
Biogen BIIB:US $ 5018M 1071.4M
Brainstorm Cell Therapeutics BCLI:US $ 7.85M 0.47M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Capricor Therapeutics CAPR:US $ 19.55M 5.22M
Cytokinetics CYTK:US $ 66.84M 0M
Eisai 4523:JP Y 301894M 11439M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Exelixis EXEL:US $ 304.52M 15.44M
Genocea Biosciences GNCA:US $ 18.03M 0.65M
Geron GERN:US $ 46.88M 0.25M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Intra Cellular Therapies ITCI:US $ 70.63M 11.56M
Ligand Pharmaceuticals LGND:US $ 167.85M 125.28M
Novartis NOVN:VX SF 27646M 2161M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M